HLA-C and neoplasm: In tumor tissue, when TCR on tumor-infiltrating T cells recognizes and binds to tumor antigen-MHC complex, T lymphocytes are activated via signal transduction and enter the subsequent immune response process, which enables immunotherapy to effectively elicit antigen-specific anti-tumor immune response (114).